Results 131 to 140 of about 96,485 (242)

Safety and efficacy of oral icotrokinra for moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Immunol
AlJuma RS, Hashim S, Alshamali MA, Alkhatlan S, Hammadi DJ, Alharran AM.   +5 more
europepmc   +1 more source

046 Correlation of a two-item patient-derived PASI with a four-component PASI [PDF]

Journal of Investigative Dermatology, 2016
J. Mounessa, D. Lynn, L. Caplan, R. Dellavalle   +3 more
openaire   +1 more source

Genital involvement and psoriasis severity. [PDF]

JAAD Int
Rêgo VRPA, Magalhães AR, Oliveira MFSP, Silva FL, Rocha FPR, Fernandes JD.   +5 more
europepmc   +1 more source

A Comparative Study of Oral Tofacitinib and Oral Methotrexate in the Treatment of Patients With Moderate to Severe Chronic Plaque Psoriasis. [PDF]

Cureus
Unnikrishnan P, Vudayana K, Chintada D, Khatija Begum M, Chalamalasetty SS, Gullipalli P.   +5 more
europepmc   +1 more source

PASI test specification

A report detailing test matrix experimental boundary conditions and needed ...
openaire   +1 more source

Predictive Factors of Early Super-Response to Biologic Agents in Psoriasis: Insights from Real-World Evidence. [PDF]

Clin Cosmet Investig Dermatol
Koç Yıldırım S, Ayyıldız SM, Demirel Öğüt N, Erbağcı E, Ünal S, Gokyayla E.   +5 more
europepmc   +1 more source

Comparative efficacy and safety of IL-17 and IL-23 inhibitors for moderate-to-severe psoriasis in Asian populations: a systematic review and meta-analysis. [PDF]

BMC Immunol
Alzghool M, Jiquan S, Bashir MB.
europepmc   +1 more source

Factors Predicting Guselkumab Treatment Response in Patients with Moderate-to-Severe Plaque Psoriasis: A Post Hoc Analysis of Korean Real-World Data. [PDF]

J Clin Med
Lee YB, Shin BS, Kim M, Suh MK, Youn SW, Lee JY, Kim CW, Lee GY, Kim KH, An J, Kim Y, Kim KJ, Kim DH, Son SW.   +13 more
europepmc   +1 more source

Real-World Effectiveness and Safety of Tapinarof 1% Cream in Psoriasis: An Observational Study From Bangladesh. [PDF]

Cureus
Huq S, Noor T, Hena Chowdhury A, Abdul Latif Khan M, Nahar Asma A, Malabeka S, Tasmin Tahnin NA, Rahman Mahin T, Al Mamun S, Jesmin A.   +9 more
europepmc   +1 more source

From Convenience to Clinical Efficacy: Selective TYK2 Inhibition in Psoriasis and the Evolving Role of Next-Generation Oral Targeted Therapies. [PDF]

Pharmaceutics
Andrzejczak K, Sternak A, Witkowski W, Karolewicz B, Ponikowska M.   +4 more
europepmc   +1 more source